Skip to the card

2026-11-21 issue

Observed arrival · 2026-11-21

BioRegen’s two-device tissue-regeneration program

bioregenbiomaterials.com Visit website
Editorial interest 72/100 Selection signal · not a rating of the site

A Chilean biomaterials venture developing a resorbable guided-bone-regeneration membrane and a chronic-wound dressing.

Landing page captured for the 2026-11-21 issue.
For
Clinical partners, distributors, and pre-seed investors
Worth noticing
The page labels the platform TRL 4 and places in-vivo preclinical studies next, before regulatory planning and clinical partnerships.

Field notes

The membrane is described as an electrospun PLA nanofiber scaffold with nHA and bioactive glass; the page includes a confocal image captioned with MC3T3 preosteoblasts and a 50 µm scale bar. BioRegen reports laboratory and cellular validation at TRL 4, while in-vivo preclinical studies, ISP regulatory planning, and clinical partnerships remain next steps on its roadmap.

Observed signals

Read the marks

Editorial observations of this landing page, not a rating.

○OpenPublic substance visible
✦PrettyNotable craft visible
◎NicheUnusually specific use

One card from the complete issue

Straw-Goat Rehearsal

333,779 arrived 1,000 judged 980 catalogued Enter the complete issue
bioregenbiomaterials.com

Landing page observed 2026-11-21. The live site may have changed.